PlenOptika is a company that spun out from the Massachusetts Institute of Technology and the Madrid–MIT M+Visión Consortium.
The founders were research fellows in a biomedical technology innovation initiative who felt compelled to solve the problem of low vision suffered by more than 1 billion people worldwide.
Our mission is to make eye care easy for anyone who needs it in the United States, and accessible to underserved and low-resource communities worldwide.
PlenOptika has been recognized by international social innovation foundations and business plan competitions. We have collaborated with research centers in the United States, Spain, and India to develop our groundbreaking technology, QuickSee.
Pelnoptika Wavefront Refraction Engine Technology was developed by Plenoptika , Inc ., an MIT spin-out(Cambridge, USA), with support from
With e-see, you can conduct auto refraction easily, anywhere—without compromising quality.
That means you can see more patients, and help them make the best vision care choices.